BrosensIRobertsonWBDixonHG. The physiological response to the vessels of the placental bed to normal pregnancy. J Pathol Bacteriol1967; 93: 569–79.
2.
RobertsonWBKhongTY. Pathology of the uteroplacental bed. In: SharpFSymondsEM eds. Perinatology press. New York: Ithaca House, 1987: 101–13.
3.
BrosensIDixonHG. The anatomy of the maternal side of the placenta. Prostaglandins Leukot Med1966; 13: 249–54.
4.
PijnenborgRDixonHGRobertsonWB. Trophoblast invasion of human decidua from 8 to 18 weeks of pregnancy. Placenta1980; 1: 3–19.
5.
PijnenborgRBlandJMRobertsonWB. The pattern of interstitial trophoblastic invasion of the myometrium in early human pregnancy. Placenta1981; 2: 303–16.
6.
PijnenborgRBlandJMRobertsonWB. Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta1983; 4: 397–414.
KhongTYde WolfFRobertsonWB. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational-age infants. Br J Obstet Gynaecol1986; 93: 1049–59.
9.
BrosensIRobertsonWBDixonHG. The role of the spiral arteries in the pathogenesis of pre-eclampsia. Obstet Gynecol Ann1972; 1: 177–91.
10.
SheppardBLBonnarJ.An ultrastructural study of uteroplacental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation. Br J Obstet Gynaecol1981; 88: 695–705.
11.
GerretsenGHuisjesHJElemaJD. Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation. Br J Obstet Gynaecol1981; 88: 877–81.
12.
ZeekPMAssaliNS. Vascular changes with eclamptogenic toxemia of pregnancy. Am J Obstet Gynecol1950; 20: 1099–109.
13.
SextonLIHertigATReidDE. Premature separation of the normally implanted placenta. Am J Obstet Gynecol1950; 59: 13–24.
14.
LabarrereCA. Acute atherosis. A histopathological hallmark of immune aggression. Placenta1988; 9: 95–108.
15.
HertigAT. Vascular pathology in the hypertensive albuminuric toxaemias of pregnancy. Clinics1945; 4: 602–13.
16.
de WolfFRobertsonWBBrosensI.The ultrastructure of acute atherosis in hypertensive pregnancy. Am J Obstet Gynecol1975; 123: 164–74.
17.
ShanklinDRSibaiBM. Ultrastructural aspects of pre-eclampsia. Am J Obstet Gynecol1989; 161: 735–41.
18.
McFadyenIRGreenhousePPriceAB. The relation between plasma urate and placental bed vascular adaptation to pregnancy. Br J Obstet Gynaecol1986; 93: 482–87.
19.
de WolfFBrosensIRenaerM.Fetal growth retardation and the maternal arterial supply of the human placenta in the absence of sustained hypertension. Br J Obstet Gynaecol1980; 87: 678–85.
20.
SheppardBLBonnerJ.The ultrastructure of the arterial supply of the human placenta in pregnancy complicated by intrauterine growth retardation. Br J Obstet Gynaecol1976; 83: 948–59.
21.
PijnenborgRAnthonyJDaveyDA. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol1991; 98: 648–55.
22.
FoxH.The placenta in pregnancy hypertension. In: RubinP ed. Handbook of hypertension, volume 10: Hypertension in pregnancy. Amsterdam: Elsevier, 1988: 16–37.
23.
PollakVENettlesJB. The kidney in toxaemia of pregnancy: A clinical and pathologic study based on renal biopsies. Medicine (Baltimore)1960; 39: 469–526.
24.
ThomsonDPatersonWGSmartGE. The renal lesions of toxaemia and abruptio placentae studied by light and electron microscopy. J Obstet Gynaecol Br Commonw1972; 72: 311–20.
25.
SheehanHLLynchJB. Pathology of toxaemia of pregnancy. London: Churchill Livingstone, 1973.
26.
SpargoBMcCartneyCPWinemillerR.Glomerular capillary endotheliosis in toxaemia of pregnancy. Arch Pathol1959; 68: 593–99.
27.
FoxH.Histopathology of pre-eclampsia and eclampsia. In: SharpFSymondsEM eds. Perinatology press. New York: Ithaca House, 1987: 119–30.
28.
RobsonJS. Proteinuria and the renal lesion of pre-eclampsia and abruptio placenta. In: LindheimerMDKatzAI eds. Hypertension in pregnancy. New York: Wiley, 976: 61–73.
29.
LindheimerMDKatzAI. The kidney in pregnancy. In: BrennerBMRectorFC eds. The kidney. Philadelphia: WB Saunders, 1986: 1253–95.
30.
ChesleyLC. Hypertensive disorders in pregnancy. New York: Appleton-Century Crofts, 1978.
31.
ButlerNRBonhamDG eds. Perinatal mortality. Edinburgh: ES Livingstone, 1963: 86–100.
32.
NaeyeRLFriedmanEA. Causes of perinatal death associated with gestational hypertension and proteinuria. Am J Obstet Gynecol1979; 133: 8–10.
33.
McEwanHP. Investigation of proteinuria in pregnancy by immunoelectrophoresis. Br J Obstet Gynaecol1968; 75: 289–94.
34.
McEwanHP. Investigation of proteinuria associated with hypertension in pregnancy. Br J Obstet Gynaecol1969; 76: 809–12.
35.
MacLeanPRPatersonWGSmartGE. Proteinuria in toxaemia and abruptio placentae. J Obstet Gynaecol Br Commonw1972; 79: 321–26.
36.
MacGillivrayI.Pre-eclampsia. The hypertensive disease of pregnancy. London: WB Saunders, 1983.
37.
BorglinNE. Serum glutamic-oxalecetic transaminase (SGO-T) and serum glutamic-pyruvic transaminase (SGP-T) in toxaemia of pregnancy. J Clin Endocrinol1959; 19: 425–31.
38.
TheisenRJacksonRMorriseyJ. Serum enzymes in normal and toxemic pregnancies. Obstet Gynecol1961; 17: 183.
39.
RomeroRVizosoJEmamianM. Clinical significance of liver dysfunction in pregnancy-induced hypertension. Am J Perinatal1988; 5: 156–51.
RichardsAGrahamDBullockR.Clinicopathological study of neurological complications due to hypertensive disorders of pregnancy. J Neurol Neurosurg Psychiatry1988; 51: 416–21.
44.
GalleryEDHunyorSNGyoryAZ. Plasma volume contraction: A significant factor in both pregnancy-associated hypertension and chronic hypertension in pregnancy. QJ Med1979; 48: 593.
45.
WallenburgHCS. Hemodynamics in hypertensive pregnancy. In: RubinP ed. Hypertension in pregnancy. Amsterdam: Elsevier, 1988: 66–101.
46.
WeirRJFraserRLeverAF. Plasma renin, renin substrate, angiotensin II and aldosterone in hypertensive disease of pregnancy. Lancet1973; i: 291–95.
47.
SkinnerSLLumbarsERSymondsEM. Analysis of charge in the renin-angiotensin system during pregnancy. Clin Sci1972; 42: 479.
48.
OatsJNBroughton-PipkinFSymondsEM. A prosepctive study of plasma angiotensin convertin enzyme in normotensive primigravidae and their infants. Br J Obstet Gynaecol1981; 88: 1204.
49.
JadoulFACBroughton-PipkinFLammingGD. Changes in the renin-angiotensin-aldosterone system in normotensive primigravidae in the four days after normal spontaneous delivery. Br J Obstet Gynaecol1982; 89: 633–37.
50.
SymondsEMStanleyMASkinnerSL. Production of renin by in vitro cultures of human chorion and uterine muscle. Nature1968; 217: 1152–53.
51.
PoisnerAMWoodGWPoisnerR. Localisation of renin in trophoblasts in human chorion laeve at term pregnancy. Endocrinology1981; 109: 1150.
52.
WarrenAYCravenDJSymondsEM. Production of active and inactive renin by cultured explants from the human female genital tract. Br J Obstet Gynaecol1982; 89: 628.
53.
JohnsonJJohnsonIRRonanJE. The site of renin in the human uterus. Histopathology1984; 8: 273.
54.
AckerGMGalenFXDevauzC. Human chorionic cells in primary culture: A model for renin biosynthesis. J Clin Endocrinol Metab1982; 55: 902–909.
55.
Abdul-KarimREAssaliNS. Pressor response to angiotonin in pregnant and non-pregnant women. Am J Obstet Gynecol1961; 82: 246.
56.
TalledoOEChesleyLCZuspanFP. Renin angiotensin system in normal and toxaemic pregnancies. III: Differential sensitivity to angiotensin II and norepinephrine in toxaemia of pregnancy. Am J Obstet Gynecol1968; 100: 2218–21.
57.
GantNFDaleySWhalleyPJ. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest1973; 52: 2682–89.
58.
EverettRBWorleyRJMacdonaldPC. Modification of vascular responsiveness to angiotensin II in pregnant women by intravenously infused 5-dihydro-progesterone. Am J Obstet Gynecol1978; 131: 352–57.
59.
ChesleyLCTepperIH. Effects of progesterone and estrogen on the sensitivity to angiotensin II. J Clin Endocrinol Metab1967; 27: 576–81.
60.
GimbroneMAAlexanderRW. Angiotensin II stimulation of prostaglandin production in cultured human vascular endothelium. Science1975; 189: 219–20.
61.
BjoroK.Effects of angiotensin I and II and their interactions with some prostanoids in perfused human umbilical arteries. Prostaglandins1985; 30: 989–98.
62.
JaspersWJMDe JohnPAMulderAW. Angiotensin II sensitivity and prostaglandin synthetase inhibition in pregnancy. Eur J Obstet Gynecol Reprod Biol1981; 11: 379.
63.
Broughton-PipkinFHunterJCTurnerSR. Prostaglandin E2 attenuates the pressor response to angiotensin II in pregnant, but not non-pregnant, humans. Am J Obstet Gynecol1982; 142: 168.
64.
Broughton-PipkinFMorrisonRO'BrienPMS. Effects of prostacyclin on the pressor response to angiotensin II in human pregnancy. Eur J Clin Invest1984; 14: 3.
65.
FranklinGODowdAJCaldwellBV. The effects of angiotensin II intravenous infusion on plasma renin and prostaglandins A, E and F levels in the uterine vein of the pregnant monkey. Prostaglandins1974; 6: 271–78.
66.
SperoffLHaninRVLevinRM. The effects of angiotensin II and indomethacin on uterine artery blood flow in pregnant monkeys. Obstet Gynecol1977; 50: 611.
67.
FerrisTFWeirEK. Effect of captopril on uterine blood flow and prostaglandin E synthesis in the pregnant rabbit. J Clin Invest1983; 71: 809–15.
68.
GalleryEDMStokesGSGyoryAZ. Plasma renin activity in normal human pregnancy and in pregnancy-associated hypertension, with reference to cryoactivation. Clin Sci1980; 59: 49.
69.
FievetPPleskovLDesaillyE. Plasma renin activity, blood uric acid and plasma volume in pregnancy-induced hypertension. Nephron1985; 40: 429.
70.
SymondsEMBroughton-PipkinFCravenDJ. Changes in the renin-angiotensin system in primigravidae with hypertensive disease of pregnancy. Br J Obstet Gynaecol1975; 82: 643.
71.
SymondsEMBroughton-PipkinF.Pregnancy hypertension, parity and the renin-angiotensin system. Am J Obstet Gynecol1978; 132: 473.
72.
KarlbergBERydenGWichmanK.Changes in the renin-angiotensin-aldosterone and kallikreinkinin systems during normal and hypertensive pregnancy. Acta Obstet Gynecol ScandSuppl1984; 118: 17.
73.
BakerPNBroughton-PipkinFSymondsEM. Platelet angiotensin II binding sites in hypertension in pregnancy. Lancet1989; ii: 1151.
74.
AalkjaerCJohannesenPPedersenEB. Morphology and angiotensin II responsiveness of isolated resistance vessels from patients with pre-eclampsia. Scand J Clin Lab Invest1984; 44 (suppl 169): 57.
75.
BjoroKStokkeKTStray-PedersonS.Fetal angiotensin induced prostanoid production is altered in pregnancy-induced hypertension. Clin Exp Hypertens1987; B6: 86.
76.
Broughton-PipkinFSymondsEM. Prostaglandins and pregnancy-induced hypertension. In: BydgemanMBergerGKeithL eds. Prostaglandins and their inhibitors in clinical obstetrics and gynaecology. Lancaster: MTP Press, 1986: 337.
77.
AikenJWVaneJR. Intrarenal prostaglandin release attenuates the renal vasoconstrictor activity of angiotensin. J Pharmacol Exp Ther1973; 184: 678–87.
78.
AbitolMMOberWBGalloGR. Experimental toxaemia of pregnancy in the monkey, with a preliminary report on renin and aldosterone. Am J Pathol1977; 86: 573–80.
79.
FranklinGODowdAJCaldwellBV. The effects of angiotensin II intravenous infusion on plasma renin and prostaglandins A, E and F levels in the uterine vein of the pregnant monkey. Prostaglandins1974; 6: 271–78.
80.
DaviesJAPrenticeCRM. Coagulation changes in pregnancy-induced hypertension and growth retardation. In: GreerIATurpieAGGForbesCD eds. Haemostasis and thrombosis in obstetrics and gynaecology. London: Chapman & Hall, 1992: 143–62.
81.
GreerIA. Pathological processes in pregnancy-induced hypertension and intrauterine growth retardation: ‘an excess of heated blood; In: GreerIATurpieAGGForbesCD eds. Haemostasis and thrombosis in obstetrics and gynaecology. London: Chapman & Hall, 1992: 163–192.
82.
DouglasJTShahMLoweGDO. Plasma fibrinopeptide A and beta-thromboglobulin in pre-eclampsia and pregnancy hypertension. Thromb Haemost1982; 47: 54–55.
83.
HowiePPrenticeCRMMcNicolGP. Coagulation, fibrinolysis and platelet function in pre-eclampsia, essential hypertension and placental insufficiency. J Obstet Gynaecol Br Commonw1971; 78: 992–1003.
84.
HowiePWBeggCBPurdieDWPrenticeCRM. Use of coagulation tests to predict the clinical progress of pre-eclampsia. Lancet1976; ii: 323–25.
85.
RedmanCWGDensonKWEBeilinLJBoltonFGStirratGM. Factor VIII consumption in pre-eclampsia. Lancet1977; ii: 1249–52.
86.
CondieRG. A serial study of coagulation factors XII, XXI and X in normal pregnancy and in pregnancy complicated by pre-eclampsia. Br J Obstet Gynaecol1976; 83: 636–39.
87.
WeinerCPBrandtJ.Plasma antithrombin III activity in normal pregnancy. Obstet Gynecol1980; 56: 601–603.
88.
WeinerCPBrandtJ.Plasma antithrombin III activity: An aid in the diagnosis of pre-eclampsia/eclampsia. Am J Obstet Gynecol1982; 142: 275–81.
89.
AznarJGilabertJEstellesAEspanaF.Fibrinolytic activity and protein C in pre-eclampsia. Thromb Haemost1986; 55: 314–17.
90.
EdgarWMcKillopCHowiePWPrenticeCRM. Composition of soluble fibrin complexes in pre-eclampsia. Thromb Res1977; 10: 567–74.
91.
EstellesAGilabertJEspanaFAznarJGomez-LechonMJ. Fibrinolysis in pre-eclampsia. Fibrinolysis1987; 1: 209–14.
92.
de BoerKLecanderIten CateJWBormJJJTreffersPE. Placental type plasminogen activator inhibitor in pre-eclampsia. Am J Obstet Gynecol1988; 158: 518–22.
93.
SpencerJADSmithMJCederholm-WilliamsSSAWilkinsonAR. Influence of pre-eclampsia on concentrations of haemostatic factors in mothers and infants. Arch Dis Child1983; 58: 739–41.
94.
OianPOmsjoIMaltauJMOsterudB.Increased sensitivity to thromboplastin synthesis in blood monocytes from pre-eclamptic patients. Br J Obstet Gynaecol1985; 92: 511–17.
95.
RedmanCWGBonnarJBeilinLJ. Early platelet consumption in pre-eclampsia. Br Med J1978; 1: 467–69.
96.
RakocziITallianFBagdanyS. Platelet life-span in normal pregnancy and pre-eclampsia as determined by a non-radioisotope technique. Thromb Res1979; 15: 553–56.
97.
RedmanCWGAllingtonMJBoltonFGStirratGM. Plasma b thromboglobulin in pre-eclampsia. Lancet1977; i: 248.
98.
SocolMLWeinerCPLouisGRehnbergKRossiEC. Platelet activation in pre-eclampsia. Am J Obstet Gynecol1985; 151: 494–97.
99.
HowiePW. The haemostatic mechanisms of pre-eclampsia. Clin Obstet Gynecol1977; 4: 595–609.
100.
AhmedYSullivanMHFElderMG. Detection of platelet desensitization in pregnancy-induced hypertension is dependent on the agonist used. Thromb Haemost1991; 65: 474–77.
101.
GreerIAWalkerJJForbesCDCalderAA. Platelet function in pregnancy induced hypertension following treatment with labetalol and low dose aspirin. Thromb Haemost1987; 46: 667–712.
102.
WallenburgHCSRotmansN.Enhanced reactivity of the platelet thromboxane pathway in normotensive and hypertensive pregnancies with insufficient fetal growth. Am J Obstet Gynecol1982; 144: 523–28.
103.
GreerIACalderAAWalkerJJLunanCBTullochI.Increased platelet reactivity in pregnancy-induced hypertension and uncomplicated diabetic pregnancy: An induction for anteplatelet therapy?Br J Obstet Gynaecol1988; 5: 1204–208.
104.
LoudenKABroughton-PipkinFHeptinstallSFoxSCMitchellJRASymondsEM. Platelet reactivity and serum thromboxane B2 production in whole blood in gestational hypertension and pre-eclampsia. Br J Obstet Gynaecol1991; 98: 1239–44.
105.
BeaufilsMUzanSDonsimoniRColauJC. Prevention of pre-eclampsia by early anti-platelet therapy. Lancet1985; i: 840–42.
106.
WallenburgHCSDekkerGAMakovitzJWRotmansP.Low dose aspirin prevents pregnancy induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet1986; i: 1–3.
107.
BussolinoFBenedettoCMassobrioMComussiG.Maternal vascular prostacyclin activity in pre-eclampsia [Letter]. Lancet1980; ii: 702.
108.
MoodleyJNormanRJReddiK.Central venous concentrations of immunoreactive prostaglandins E, F and 6-keto-prostaglandin F1 in eclampsia. Br Med J1984; 288: 1487–89.
109.
GoodmanRPKillamAPBrashARBranchRA. Prostacyclin production during pregnancy: Comparison of production during normal pregnancy and pregnancy complicated by hypertension. Am J Obstet Gynecol1982; 142: 817–22.
110.
GreerIA. The effect of anti-hypertensive agents on platelets, prostacyclin and thromboxane and observations on prostacyclin and thromboxane in normal and hypertensive pregnancy [Thesis]. University of Glasgow, 1985.
111.
GreerIAWalkerJJCameronADMcLarenMCalderAAForbesCD. A prospective longitudinal study of immunoreactive prostacyclin and thromboxane metabolites in normal and hypertensive pregnancies. Clin Exp Hypertens1985; 4: 167–82.
112.
WalshSW. Pre-eclampsia: An imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol1985; 152: 335–40.
113.
WalshSEWangYMaynardELJesseRL. Low dose aspirin inhibits abnormally increased levels of both thromboxane and lipid peroxides in pre-eclamptic placentas. Society of Gynaecological Investigators, 39th Annual Meeting, San Antonio, 1992: Abstract no. 172
114.
RemuzziGMisianiRMuratoreD. Prostacyclin and human foetal circulation. Prostaglandins1979; 18: 341–48.
115.
DowningIShepherdGLLewisPJ. Reduced prostacyclin production in pre-eclampsia [Letter]. Lancet1980; ii: 1374.
116.
WalshSWBehrMJAllenNH. Placental prostacyclin production in normal and toxemic pregnancies. Am J Obstet Gynecol1985; 151: 110–15.
117.
McLarenMGreerIAWalkerJJ. Umbilical artery perfusion: A method to measure prostacyclin production in vitro. Prog Lipid Res1986; 25: 311–15.
118.
McLarenMGreerIAWalkerJJForbesCD. Reduced prostacyclin production by umbilical arteries from pregnancy complicated by severe pregnancy induced hypertension. Clin Exp Hypertens1987; B6. 365–74.
119.
TuvemoT.Role of prostaglandins, prostacyclin and thromboxanes in the control of the umbilicalplacental circulation. Semin Perinatal1980; 4: 91–95.
120.
GreerIALeaskRHodsonBA. Endothelin, elastase and endothelial dysfunction in pre-eclampsia. Lancet1991; i: 558.
121.
NovaASibaiBMBartonJRMercerBMMitchellMD. Maternal plasma level of endothelin is increased in pre-eclampsia. Am J Obstet Gynecol1991; 65: 724–27.
122.
HarlanJD. Neutrophil-mediated vascular injury. Acta Med Scand1987; 715 (suppl): 123–29.
123.
BrayMA. The pharmacology and pathophysiology of leukotriene B4. Br Med Bull1983; 39: 249–54.
GreerIADawesJJohnstonTACalderAA. Neutrophil activation is confined to the maternal circulation in pregnancy induced hypertension. Obstet Gynecol1991; 78: 28–32.
126.
ButterworthBGreerIAListonWA. Immunocytochemical localization of neutrophil elastase in term placenta decidua and myometrium in pregnancy-induced hypertension. Br J Obstet Gynaecol1991; 98: 929–33.
127.
MillerDKSandowskiSSodermanDD. Endothelial cell prostacyclin production induced by activated neutrophils. J Biol Chem1985; 260: 1006–14.
128.
AgerAGordonJL. Differential effects of hydrogen peroxide on indices of endothelial cell function. J Exp Med1984; 159: 592–603.
129.
PologeLGCramerEVPawlowskiNA. Stimulation of human endothelial cell prostacyclin synthesis by select leukotrienes. J Exp Med1984; 160: 1043–53.
130.
WarsoMALandsWEM. Lipid peroxidation in relation to prostacyclin and thromboxane physiology and pathophysiology. Br Med Bull1983; 39: 277–80.
131.
GreerIAHaddadNGDawesJ. Increased neutrophil activation in diabetic pregnancy and non-pregnant diabetic women. Obstet Gynecol1989; 74: 878–81.
132.
JohnstonTAGreerIADawesJCalderAA. Neutrophil activation in small for gestational age pregnancies. Br J Obstet Gynaecol1991; 98: 104–105.
133.
RodgersGMTaylorRNRobertsJM. Pre-eclampsia is associated with a serum factor cytotoxic to human endothelial cells. Am J Obstet Gynecol1988; 59: 908–14.
134.
TulenkoTSchneiderJFloroC. The in vitro effect on arterial wall function of serum from patients with pregnancy induced hypertension. Am J Obstet Gynecol1987; 156: 817–23.
135.
GreerIABelchJJF. Prostacyclin pregnancy-induced hypertension, Raynaud's phenomenon and haemolytic uraemic syndrome. In: WilliamsEB ed. Current clinical concepts: Prostacyclin past, present and future. Kent: MCS, 1986: 37–45.
136.
BelchJJFThorburnJGreerIA. Intravenous prostacyclin in the management of pregnancies complicated by severe hypertension. Clin Exp Hypertens1985; B4: 75–86.
137.
GreerIAWalkerJJForbesCD. The low dose aspirin controversy solved at last?Br Med J1986; 391: 1277–78.
138.
HeaveyDGBarrowSEHicklingNE. Aspirin causes short-lived inhibitino of bradykininstimulated prostacyclin production in man. Nature1985; 318: 186–88.
139.
SinzingerHVirgoliniIPeskarBA. Response of thromboxane B2, malondialdehyde and platelet sensitivity to 3 weeks low dose aspirin in healthy volunteers. Thromb Res1989; 53: 261–69.
140.
FitzgeraldGAOatsJAHawigerJ. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest1983; 71: 676–88.
141.
FitzgeraldDJMayoGCatellaF. Increased thromboxane biosynthesis in normal pregnancy is mainly derived from platelets. Am J Obstet Gynecol1987; 157: 325–30.
142.
StuartMJGrossSJElradH. Effects of acetylsalicylic acid ingestion on maternal and neonatal hemostasis. N Engl J Med1982: 307: 909–12.
143.
RitterJMFarquarDRodinA. Low dose aspirin treatment in late pregnancy differentially inhibits cyclo-oxygenase in maternal platelets. Prostaglandins1987; 34: 717–22.
144.
GreerIAJohnstonTACalderAA. Maternal and neonatal platelet function in normal and growth retarded pregnancies. Br J Haematol1991; 77 (suppl 1): 78.
145.
LoudenKAHeptinstallSBroughton-PipkinF. The effect of low dose aspirin on platelet reactivity in pregnancy, PIH and neonates. Clin Exp Hypertens1989; 88: 398.
146.
SibaiBMMirroRChesneyCM. Low dose aspirin in pregnancy. Obstet Gynecol1989; 74: 551–57.
147.
SchiffEPelegEGoldenbergM. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high pregnancies. N Engl J Med1989; 321: 351–56.
148.
GantNFChandSWorleyRJ. A clinical test useful for predicting the development of acute hypertension in pregnancy. Am J Obstet Gynecol1974; 120: 1–7.
149.
PhelenJPEveridgeGJWilderTL. Is the supine pressor test an adequate means of predicting acute hypertension in pregnancy?Am J Obstet Gynecol1977; 128: 173–76.
150.
BenigniAGregoriniGFruscaT. Effect of low dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy induced hypertension. N Engl J Med1989; 321: 357–62.
151.
Van AsscheFASpitzB.Thromboxane synthetase inhibition in pregnancy-induced hypertension. Am J Obstet Gynecol1988; 159: 1015–16.
152.
Van AsscheFASpitzBVermylenJ. Preliminary observations on treatment of pregnancy-induced hypertension with a thromboxane synthetase inhibitor. Am J Obstet Gynecol1984; 148: 216–18.
153.
GreerIAWalkerJJMcLarenM. A comparative study of the effects of adrenoceptor antagonists on platelet aggregation and thromboxane generation. Thromb Hemost1985; 54: 480–84.
154.
GreerIAWalkerJJCalderAA. Inhibition of platelet aggregation in whole blood by adrenoceptor antagonists. Thromb Res1985; 40: 631–43.
155.
GreerIAWalkerJJMcLarenM. Inhibition of thromboxane and prostacyclin production in whole blood by adrenoceptor antagonists. Prostaglandins Leukot Med1985; 19: 209–17.
156.
GreerIAMcLarenMForbesCD. Synergistic inhibitory effects of adrenoceptor antagonists and prostacyclin and umbilical artery derived prostacyclin like activity on platelet aggregation. Eur J Obstet Gynecol Reprod Biol1990; 35: 109–18.
157.
GreerIAWalkerJJCalderAA. Influence of treatment on platelet consumption and thromboxane in pregnancy induced hypertension. Arch Gynecol1985; 237: 109.
158.
GreerIAWalkerJJForbesCD. Platelet function in pregnancy induced hypertension following treatment with labetalol and low dose aspirin. Thromb Res1987; 46: 667–72.
159.
SibaiBMGonzalezARMabieWC. A comparison of labetalol plus hospitalisation alone in the management of pre-eclampsia remote from term. Obstet Gynecol1987; 70: 323–27.
160.
GreerIAWalkerJJMcLarenM. Inhibition of whole blood platelet aggregation by nicardipine and synergism with prostacyclin in vitro. Thromb Res1986; 41: 509–51.
161.
GreerIA. Platelet function and calcium channel blocking agents. J Clin Pharm Ther1987; 12: 213–22.
162.
RubinPCButtersLMcCabeR.Nifedipine and platelets in pre-eclampsia. Am J Hypertens1988; 1: 175–77.
163.
GreerIAWalkerJJBjornssonS. Second line therapy with nifedipine in severe pregnancy induced hypertension. Clin Exp Hypertens1989; B8: 277–92.
164.
GreerIAWalkerJJMcLarenM. The effect of endralazine and hydralazine on platelet thromboxane production in vitro. Clin Exp Hypertens1988; B6: 375–86.
165.
GreerIAWalkerJJCalderAA. Aspirin with an adrenergic or a calcium channel blocking agent as new combination therapy for arterial thrombosis. Lancet1985; i: 351–52.